Opinions of Company Representatives About Neuromodulation
Completed
- Conditions
- NeuromodulationPainSurvey
- Registration Number
- NCT05013827
- Lead Sponsor
- Moens Maarten
- Brief Summary
The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 39
Inclusion Criteria
- Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain as company representatives will be eligible to complete the survey.
Exclusion Criteria
- Not a company representative.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Goals of company representatives, evaluated with a self-constructed question. Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September. Goals of company representatives to treat patients with neuromodulation for pain.
Company representatives expectations, evaluated with a self-constructed question. Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September. Factors that respondents expect to change according to neuromodulation for pain.
Company representatives definition of success of neuromodulation for pain, evaluated with a self-constructed question. Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September. Company representatives their definition of success of neuromodulation for pain.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Vrije Universiteit Brussel
🇧🇪Jette, Belgium
Vrije Universiteit Brussel🇧🇪Jette, Belgium